Last reviewed · How we verify

NCT03477747

The Application of Microcurrent in Athletes

Completed NA Last updated 17 April 2019
What this trial tests

NA trial testing Microcurrent in Training Group, Sensitivity in 30 participants. Completed in 31 December 2018.

Timeline
2 January 2018
Primary endpoint
31 December 2018
31 December 2018

Quick facts

Lead sponsorUniversity of Greenwich
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment30
Start date2 January 2018
Primary completion31 December 2018
Estimated completion31 December 2018
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Greenwich

Who can join

Adults 20 to 45, any sex, with Training Group, Sensitivity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this investigation is to analyse the potential benefits of wearing a new commercially available microcurrent device combined with different exercise training modalities on exercise outcomes, body composition, recovery including muscle damage, general markers of health and immune function in athletes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effectiveness of combining microcurrent with resistance training in trained males.
    Naclerio F, Seijo M, Karsten B, Brooker G, et al · · 2019 · cited 12× · PMID 31624949 · DOI 10.1007/s00421-019-04243-1

Verify or expand the search:

Other trials of Microcurrent

Trials testing the same drug.

Other recruiting trials for Training Group, Sensitivity

Currently open trials in the same condition.

Other University of Greenwich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03477747.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing